Activation of GPR18 by Resolvin D2 Relieves Pain and Improves Bladder Function in Cyclophosphamide-Induced Cystitis Through Inhibiting TRPV1

References

• HannoPM, BurksDA, ClemensJQ, et al. AUA guideline for the diagnosis and treatment of interstitial cystitis/bladder pain syndrome. J Urol. 2011;185(6):2162–2170. doi:10.1016/j.juro.2011.03.06421497847
   PubMed Web of Science ®Google Scholar
• ClemensJQ, LinkCL, EggersPW, KusekJW, NybergLM Jr., McKinlayJB. Prevalence of painful bladder symptoms and effect on quality of life in black, Hispanic and white men and women. J Urol. 2007;177(4):1390–1394. doi:10.1016/j.juro.2006.11.08417382739
   PubMed Web of Science ®Google Scholar
• AngerJT, ZabihiN, ClemensJQ, PayneCK, SaigalCS, RodriguezLV. Treatment choice, duration, and cost in patients with interstitial cystitis and painful bladder syndrome. Int Urogynecol J. 2011;22(4):395–400. doi:10.1007/s00192-010-1252-820811877
   PubMed Web of Science ®Google Scholar
• RiedlC, EngelhardtP, SchwarzB. Treatment costs of bladder pain syndrome/interstitial cystitis in Austria: a pharmacoeconomic approach following current guidelines. Clin Drug Investig. 2013;33(10):737–742. doi:10.1007/s40261-013-0119-4
   Web of Science ®Google Scholar
• PeyronnetB, MironskaE, ChappleC, et al. A comprehensive review of overactive bladder pathophysiology: on the way to tailored treatment. Eur Urol. 2019;75(6):988–1000. doi:10.1016/j.eururo.2019.02.03830922690
   PubMed Web of Science ®Google Scholar
• PatnaikSS, LaganaAS, VitaleSG, et al. Etiology, pathophysiology and biomarkers of interstitial cystitis/painful bladder syndrome. Arch Gynecol Obstet. 2017;295(6):1341–1359. doi:10.1007/s00404-017-4364-228391486
   PubMed Web of Science ®Google Scholar
• AkiyamaY, LuoY, HannoPM, MaedaD, HommaY. Interstitial cystitis/bladder pain syndrome: the evolving landscape, animal models and future perspectives. Int J Urol. 2020;27(6):491–503. doi:10.1111/iju.1422932246572
   PubMed Web of Science ®Google Scholar
• PiomelliD. The molecular logic of endocannabinoid signalling. Nat Rev Neurosci. 2003;4(11):873–884. doi:10.1038/nrn124714595399
   PubMed Web of Science ®Google Scholar
• WallaceMS, MarcotteTD, UmlaufA, GouauxB, AtkinsonJH. Efficacy of inhaled cannabis on painful diabetic neuropathy. J Pain. 2015;16(7):616–627. doi:10.1016/j.jpain.2015.03.00825843054
   PubMed Web of Science ®Google Scholar
• WilseyB, MarcotteT, DeutschR, GouauxB, SakaiS, DonagheH. Low-dose vaporized cannabis significantly improves neuropathic pain. J Pain. 2013;14(2):136–148. doi:10.1016/j.jpain.2012.10.00923237736
   PubMed Web of Science ®Google Scholar
• Corey-BloomJ, WolfsonT, GamstA, et al. Smoked cannabis for spasticity in multiple sclerosis: a randomized, placebo-controlled trial. CMAJ. 2012;184(10):1143–1150. doi:10.1503/cmaj.11083722586334
   PubMed Web of Science ®Google Scholar
• KimSD, ChoKJ, KimJC. Expression of cannabinoid 1 and, 2 receptors and the effects of cannabinoid 1 and, 2 receptor agonists on detrusor overactivity associated with bladder outlet obstruction in rats. BMC Urol. 2017;17(1):121. doi:10.1186/s12894-017-0313-429284441
   PubMed Web of Science ®Google Scholar
• Goncalves dos SantosG, LiR, NgMPE, et al. CB1 receptor-dependent desensitisation of TRPV1 channels contributes to the analgesic effect of dipyrone in sensitised primary sensory neurons. Br J Pharmacol. 2020;177(20):4615–4626. doi:10.1111/bph.1517032562269
   PubMed Web of Science ®Google Scholar
• SanthaP, JenesA, SomogyiC, NagyI. The endogenous cannabinoid anandamide inhibits transient receptor potential vanilloid type 1 receptor-mediated currents in rat cultured primary sensory neurons. Acta Physiol Hung. 2010;97(2):149–158. doi:10.1556/APhysiol.97.2010.2.120511124
   PubMedGoogle Scholar
• YeY, ScheffNN, BernabeD, et al. Anti-cancer and analgesic effects of resolvin D2 in oral squamous cell carcinoma. Neuropharmacology. 2018;139:182–193. doi:10.1016/j.neuropharm.2018.07.01630009833
   PubMed Web of Science ®Google Scholar
• PernaE, Aguilera-LizarragaJ, FlorensMV, et al. Effect of resolvins on sensitisation of TRPV1 and visceral hypersensitivity in IBS. Gut. 2021;70(7):1275–1286. doi:10.1136/gutjnl-2020-32153033023902
   PubMed Web of Science ®Google Scholar
• BoucherM, MeenM, CodronJP, CoudoreF, KemenyJL, EschalierA. Cyclophosphamide-induced cystitis in freely-moving conscious rats: behavioral approach to a new model of visceral pain. J Urol. 2000;164(1):203–208. doi:10.1097/00005392-200007000-0006110840460
   PubMed Web of Science ®Google Scholar
• ZhangLY, LiuZH, ZhuQ, et al. Resolvin D2 relieving radicular pain is associated with regulation of inflammatory mediators, Akt/GSK-3beta signal pathway and GPR18. Neurochem Res. 2018;43(12):2384–2392. doi:10.1007/s11064-018-2666-930443715
   PubMed Web of Science ®Google Scholar
• LeeSH, TonelloR, ImST, et al. Resolvin D3 controls mouse and human TRPV1-positive neurons and preclinical progression of psoriasis. Theranostics. 2020;10(26):12111–12126. doi:10.7150/thno.5213533204332
   PubMed Web of Science ®Google Scholar
• Lanteri-MinetM, BonK, de PommeryJ, MichielsJF, MenetreyD. Cyclophosphamide cystitis as a model of visceral pain in rats: model elaboration and spinal structures involved as revealed by the expression of c-Fos and Krox-24 proteins. Exp Brain Res. 1995;105(2):220–232. doi:10.1007/BF002409587498375
   PubMed Web of Science ®Google Scholar
• ChaplanSR, BachFW, PogrelJW, ChungJM, YakshTL. Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods. 1994;53(1):55–63. doi:10.1016/0165-0270(94)90144-97990513
   PubMed Web of Science ®Google Scholar
• CharruaA, CruzCD, CruzF, AvelinoA. Transient receptor potential vanilloid subfamily 1 is essential for the generation of noxious bladder input and bladder overactivity in cystitis. J Urol. 2007;177(4):1537–1541. doi:10.1016/j.juro.2006.11.04617382774
   PubMed Web of Science ®Google Scholar
• CharruaA, CruzCD, JansenD, RozenbergB, HeesakkersJ, CruzF. Co-administration of transient receptor potential vanilloid 4 (TRPV4) and TRPV1 antagonists potentiate the effect of each drug in a rat model of cystitis. BJU Int. 2015;115(3):452–460. doi:10.1111/bju.1286125041193
   PubMed Web of Science ®Google Scholar
• AhluwaliaJ, UrbanL, CapognaM, BevanS, NagyI. Cannabinoid 1 receptors are expressed in nociceptive primary sensory neurons. Neuroscience. 2000;100(4):685–688. doi:10.1016/s0306-4522(00)00389-411036202
   PubMed Web of Science ®Google Scholar
• ConsroeP, MustyR, ReinJ, TilleryW, PertweeR. The perceived effects of smoked cannabis on patients with multiple sclerosis. Eur Neurol. 1997;38(1):44–48. doi:10.1159/000112901
   PubMed Web of Science ®Google Scholar
• MerriamFV, WangZY, GueriosSD, BjorlingDE. Cannabinoid receptor 2 is increased in acutely and chronically inflamed bladder of rats. Neurosci Lett. 2008;445(1):130–134. doi:10.1016/j.neulet.2008.08.07618778751
   PubMed Web of Science ®Google Scholar
• BakaliE, McDonaldJ, ElliottRA, LambertDG, TincelloDG. Cannabinoid receptor expression in the bladder is altered in detrusor overactivity. Int Urogynecol J. 2016;27(1):129–139. doi:10.1007/s00192-015-2802-x26224382
   PubMed Web of Science ®Google Scholar
• HommaY. Interstitial cystitis, bladder pain syndrome, hypersensitive bladder, and interstitial cystitis/bladder pain syndrome - clarification of definitions and relationships. Int J Urol. 2019;26(Suppl 1):20–24. doi:10.1111/iju.1397031144731
   PubMed Web of Science ®Google Scholar
• Farquhar-SmithWP, RiceAS. Administration of endocannabinoids prevents a referred hyperalgesia associated with inflammation of the urinary bladder. Anesthesiology. 2001;94(3):507–13; discussion 6A. doi:10.1097/00000542-200103000-00023
   Web of Science ®Google Scholar
• WangZY, WangP, BjorlingDE. Activation of cannabinoid receptor 2 inhibits experimental cystitis. Am J Physiol Regul Integr Comp Physiol. 2013;304(10):R846–R853. doi:10.1152/ajpregu.00585.201223515618
   PubMed Web of Science ®Google Scholar
• Farquhar-SmithWP, JaggarSI, RiceAS. Attenuation of nerve growth factor-induced visceral hyperalgesia via cannabinoid CB(1) and CB(2)-like receptors. Pain. 2002;97(1–2):11–21. doi:10.1016/s0304-3959(01)00419-512031775
   PubMed Web of Science ®Google Scholar
• GuX, MeiF, LiuY, ZhangR, ZhangJ, MaZ. Intrathecal administration of the cannabinoid 2 receptor agonist JWH015 can attenuate cancer pain and decrease mRNA expression of the 2B subunit of N-methyl-D-aspartic acid. Anesth Analg. 2011;113(2):405–411. doi:10.1213/ANE.0b013e31821d106221519057
   PubMed Web of Science ®Google Scholar
• CuiJH, KimWM, LeeHG, KimYO, KimCM, YoonMH. Antinociceptive effect of intrathecal cannabinoid receptor agonist WIN 55,212-2 in a rat bone tumor pain model. Neurosci Lett. 2011;493(3):67–71. doi:10.1016/j.neulet.2010.12.05221195743
   PubMed Web of Science ®Google Scholar
• FabisiakA, FabisiakN, MokrowieckaA, et al. Novel selective agonist of GPR18, PSB-KK-1415 exerts potent anti-inflammatory and anti-nociceptive activities in animal models of intestinal inflammation and inflammatory pain. Neurogastroenterol Motil. 2021;33(3):e14003. doi:10.1111/nmo.1400333058313
   PubMed Web of Science ®Google Scholar
• HuangSM, BisognoT, PetrosTJ, et al. Identification of a new class of molecules, the arachidonyl amino acids, and characterization of one member that inhibits pain. J Biol Chem. 2001;276(46):42639–42644. doi:10.1074/jbc.M10735120011518719
   PubMed Web of Science ®Google Scholar
• WrobelA, ZapalaL, ZapalaP, PiechaT, RadziszewskiP. The effect of O-1602, a GPR55 agonist, on the cyclophosphamide-induced rat hemorrhagic cystitis. Eur J Pharmacol. 2020;882:173321. doi:10.1016/j.ejphar.2020.17332132615180
   PubMed Web of Science ®Google Scholar
• WrobelA, SzopaA, SerefkoA, PoleszakE, NovelA. Alternative in the treatment of detrusor overactivity? In vivo activity of O-1602, the newly synthesized agonist of GPR55 and GPR18 Cannabinoid receptors. Molecules. 2020;25(6):1384. doi:10.3390/molecules25061384
   Web of Science ®Google Scholar
• WrobelA, SerefkoA, SzopaA, UlrichD, PoleszakE, RechbergerT. O-1602, an agonist of atypical Cannabinoid receptors GPR55, reverses the symptoms of depression and detrusor overactivity in rats subjected to corticosterone treatment. Front Pharmacol. 2020;11:1002. doi:10.3389/fphar.2020.0100232733244
   PubMed Web of Science ®Google Scholar
• FowlerCJ, GriffithsD, de GroatWC. The neural control of micturition. Nat Rev Neurosci. 2008;9(6):453–466. doi:10.1038/nrn240118490916
   PubMed Web of Science ®Google Scholar
• YoshimuraN, SekiS, ChancellorMB, de GroatWC, UedaT. Targeting afferent hyperexcitability for therapy of the painful bladder syndrome. Urology. 2002;59(5 Suppl 1):61–67. doi:10.1016/s0090-4295(01)01639-912007524
   PubMed Web of Science ®Google Scholar
• NazifO, TeichmanJ, GebhartG. Neural upregulation in interstitial cystitis. Urology. 2007;69(4):24–33. doi:10.1016/j.urology.2006.08.110817462476
   PubMed Web of Science ®Google Scholar
• KeastJR, De GroatWC. Segmental distribution and peptide content of primary afferent neurons innervating the urogenital organs and colon of male rats. J Comp Neurol. 1992;319(4):615–623. doi:10.1002/cne.9031904111619047
   PubMed Web of Science ®Google Scholar
• MerrillL, GonzalezEJ, GirardBM, VizzardMA. Receptors, channels, and signalling in the urothelial sensory system in the bladder. Nat Rev Urol. 2016;13(4):193–204. doi:10.1038/nrurol.2016.1326926246
   PubMed Web of Science ®Google Scholar
• LiuBL, YangF, ZhanHL, et al. Increased severity of inflammation correlates with elevated expression of TRPV1 nerve fibers and nerve growth factor on interstitial cystitis/bladder pain syndrome. Urol Int. 2014;92(2):202–208. doi:10.1159/00035517524458144
   PubMed Web of Science ®Google Scholar
• DicksonA, AvelinoA, CruzF, Ribeiro-da-silvaA. Peptidergic sensory and parasympathetic fiber sprouting in the mucosa of the rat urinary bladder in a chronic model of cyclophosphamide-induced cystitis. Neuroscience. 2006;141(3):1633–1647. doi:10.1016/j.neuroscience.2006.06.00716989017
   PubMed Web of Science ®Google Scholar
• YoshimuraN, de GroatWC. Increased excitability of afferent neurons innervating rat urinary bladder after chronic bladder inflammation. J Neurosci. 1999;19(11):4644–4653. doi:10.1523/jneurosci.19-11-04644.199910341262
   PubMed Web of Science ®Google Scholar
• YuY, de GroatWC. Sensitization of pelvic afferent nerves in the in vitro rat urinary bladder-pelvic nerve preparation by purinergic agonists and cyclophosphamide pretreatment. Am J Physiol Renal Physiol. 2008;294(5):F1146–56. doi:10.1152/ajprenal.00592.200718322018
   PubMed Web of Science ®Google Scholar
• HablerHJ, JanigW, KoltzenburgM. Activation of unmyelinated afferent fibres by mechanical stimuli and inflammation of the urinary bladder in the cat. J Physiol. 1990;425(1):545–562. doi:10.1113/jphysiol.1990.sp0181172213588
   PubMed Web of Science ®Google Scholar
• TakedaM, MochizukiT, YoshiyamaM, et al. Sensor mechanism and afferent signal transduction of the urinary bladder: special focus on transient receptor potential ion channels. Low Urin Tract Symptoms. 2010;2(2):51–60. doi:10.1111/j.1757-5672.2010.00074.x26676284
   PubMed Web of Science ®Google Scholar
• DangK, BielefeldtK, GebhartGF. Cyclophosphamide-induced cystitis reduces ASIC channel but enhances TRPV1 receptor function in rat bladder sensory neurons. J Neurophysiol. 2013;110(2):408–417. doi:10.1152/jn.00945.201223636721
   PubMed Web of Science ®Google Scholar
• CoelhoA, Wolf-JohnstonAS, ShindeS, et al. Urinary bladder inflammation induces changes in urothelial nerve growth factor and TRPV1 channels. Br J Pharmacol. 2015;172(7):1691–1699. doi:10.1111/bph.1295825297375
   PubMed Web of Science ®Google Scholar
• GrundyL, CaldwellA, Garcia CaraballoS, et al. Histamine induces peripheral and central hypersensitivity to bladder distension via the histamine H1 receptor and TRPV1. Am J Physiol Renal Physiol. 2020;318(2):F298–F314. doi:10.1152/ajprenal.00435.201931790304
   PubMed Web of Science ®Google Scholar
• ApostolidisA, BradyCM, YiangouY, DavisJ, FowlerCJ, AnandP. Capsaicin receptor TRPV1 in urothelium of neurogenic human bladders and effect of intravesical resiniferatoxin. Urology. 2005;65(2):400–405. doi:10.1016/j.urology.2004.10.00715708075
   PubMed Web of Science ®Google Scholar
• BradyCM, ApostolidisAN, HarperM, et al. Parallel changes in bladder suburothelial vanilloid receptor TRPV1 and pan-neuronal marker PGP9.5 immunoreactivity in patients with neurogenic detrusor overactivity after intravesical resiniferatoxin treatment. BJU Int. 2004;93(6):770–776. doi:10.1111/j.1464-410X.2003.04722.x15049988
   PubMed Web of Science ®Google Scholar
• WangZY, WangP, MerriamFV, BjorlingDE. Lack of TRPV1 inhibits cystitis-induced increased mechanical sensitivity in mice. Pain. 2008;139(1):158–167. doi:10.1016/j.pain.2008.03.02018445509
   PubMed Web of Science ®Google Scholar
• DornellesFN, AndradeEL, CamposMM, CalixtoJB. Role of CXCR2 and TRPV1 in functional, inflammatory and behavioural changes in the rat model of cyclophosphamide-induced haemorrhagic cystitis. Br J Pharmacol. 2014;171(2):452–467. doi:10.1111/bph.1246724117268
   PubMed Web of Science ®Google Scholar
• WalczakJS, PriceTJ, CerveroF. Cannabinoid CB1 receptors are expressed in the mouse urinary bladder and their activation modulates afferent bladder activity. Neuroscience. 2009;159(3):1154–1163. doi:10.1016/j.neuroscience.2009.01.05019356696
   PubMed Web of Science ®Google Scholar
• WalczakJS, CerveroF. Local activation of cannabinoid CB(1) receptors in the urinary bladder reduces the inflammation-induced sensitization of bladder afferents. Mol Pain. 2011;7:31. doi:10.1186/1744-8069-7-3121554718
   PubMed Web of Science ®Google Scholar
• ChristieS, ZagorodnyukV. CB2 cannabinoid receptor agonist selectively inhibits the mechanosensitivity of mucosal afferents in the Guinea pig bladder. Am J Physiol Renal Physiol. 2021;320(5):F859–F865. doi:10.1152/ajprenal.00065.202133749323
   PubMed Web of Science ®Google Scholar
• AizawaN, GandagliaG, HedlundP, et al. URB937, a peripherally restricted inhibitor for fatty acid amide hydrolase, reduces prostaglandin E2 -induced bladder overactivity and hyperactivity of bladder mechano-afferent nerve fibres in rats. BJU Int. 2016;117(5):821–828. doi:10.1111/bju.1322326189783
   PubMed Web of Science ®Google Scholar
• GratzkeC, StrengT, ParkA, et al. Distribution and function of cannabinoid receptors 1 and 2 in the rat, monkey and human bladder. J Urol. 2009;181(4):1939–1948. doi:10.1016/j.juro.2008.11.07919237169
   PubMed Web of Science ®Google Scholar
• PatelHJ, BirrellMA, CrispinoN, et al. Inhibition of Guinea-pig and human sensory nerve activity and the cough reflex in Guinea-pigs by cannabinoid (CB2) receptor activation. Br J Pharmacol. 2003;140(2):261–268. doi:10.1038/sj.bjp.070543512970104
   PubMed Web of Science ®Google Scholar
• YangY, ZhangH, LuQ, et al. Suppression of adenosine A2a receptors alleviates bladder overactivity and hyperalgesia in cyclophosphamide-induced cystitis by inhibiting TRPV1. Biochem Pharmacol. 2021;183:114340. doi:10.1016/j.bcp.2020.11434033189675
   PubMed Web of Science ®Google Scholar
• WoutersMM, BalemansD, Van WanrooyS, et al. Histamine receptor H1-mediated sensitization of TRPV1 mediates visceral hypersensitivity and symptoms in patients with irritable bowel syndrome. Gastroenterology. 2016;150(4):875–87 e9. doi:10.1053/j.gastro.2015.12.03426752109
   PubMed Web of Science ®Google Scholar
• BalemansD, BoeckxstaensG, TalaveraK, WoutersM. Transient receptor potential ion channel function in sensory transduction and cellular signaling cascades underlying visceral hypersensitivity. Am J Physiol Gastrointest Liver Physiol. 2017;312(6):G635–G648. doi:10.1152/ajpgi.00401.201628385695
   PubMed Web of Science ®Google Scholar